SCHEMBL9959972

SCHEMBL9959972

COCOc1c(F)cc2ccccc2c1-c1c(OCOC)c(F)cc2ccccc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.41
▸ KDM4E B2RXH2 3/20 0.41
▸ NPSR1 Q6W5P4 2/20 0.41
▸ HPGD P15428 1/20 0.41
▸ MAPT P10636 3/20 0.36
▸ TRPA1 O75762 1/20 0.33
▸ HPRT1 P00492 1/20 0.33
▸ ERN1 O75460 1/20 0.32
▸ MAPK1 P28482 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ MEN1 O00255 1/20 0.31
▸ KMT2A Q03164 1/20 0.31
▸ ALOX5 P09917 1/20 0.31
▸ PTPN1 P18031 1/20 0.31
▸ HTR2A P28223 1/20 0.31
▸ NQO1 P15559 1/20 0.31
▸ L3MBTL1 Q9Y468 1/20 0.31
▸ CYP1A2 P05177 1/20 0.31
▸ CYP2A6 P11509 1/20 0.31
▸ TUBB4A P04350 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23242265 0.87 TRPA1 (0.33) ALDH1A1KDM4ENPSR1HPGDTRPA1
SCHEMBL15804376 0.82 ALDH1A1 (0.42) ALDH1A1KDM4ENPSR1HPGDMAPT
SCHEMBL14315820 0.81 KDM4E (0.46) ALDH1A1KDM4ENPSR1HPGDMAPT
SCHEMBL16222497 0.81 ALDH1A1 (0.54) ALDH1A1KDM4ENPSR1HPGDMAPT
SCHEMBL3920626 0.81 ALDH1A1 (0.41) ALDH1A1KDM4ENPSR1HPGDMAPT
SCHEMBL669045 0.81 ALDH1A1 (0.41) ALDH1A1KDM4ENPSR1HPGDMAPT
SCHEMBL29868208 0.81 ALDH1A1 (0.41) ALDH1A1KDM4ENPSR1HPGDMAPT
SCHEMBL22229789 0.81 KDM4E (0.37) ALDH1A1KDM4ENPSR1HPGDMAPT
SCHEMBL15206461 0.80 HSD11B1 (0.39) ALDH1A1KDM4ENPSR1HPGDMAPT
SCHEMBL6130240 0.78 GPR84 (0.42) ALDH1A1KDM4ENPSR1HPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8975447-B2 Process for asymetric methylallylation in the presence of a 2,2′-substituted 1,1′-BI-2-naphthol catalyst BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2015-03-10 — — US disclosed
US-8975447-B2 Process for asymetric methylallylation in the presence of a 2,2′-substituted 1,1′-BI-2-naphthol catalyst BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2015-03-10 — — US disclosed
US-8975447-B2 Process for asymetric methylallylation in the presence of a 2,2′-substituted 1,1′-BI-2-naphthol catalyst BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2015-03-10 — — US disclosed
US-8916701-B2 Methods of making diastereomeric organic compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-12-23 — — US disclosed
US-8916701-B2 Methods of making diastereomeric organic compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-12-23 — — US disclosed
US-8916701-B2 Methods of making diastereomeric organic compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-12-23 — — US disclosed
EP-2655349-B1 METHODS OF MAKING DIASTEREOMERIC ORGANIC COMPOUNDS BOEHRINGER INGELHEIM INT (DE) 2014-10-15 — — EP disclosed
EP-2655349-B1 METHODS OF MAKING DIASTEREOMERIC ORGANIC COMPOUNDS BOEHRINGER INGELHEIM INT (DE) 2014-10-15 — — EP disclosed
US-20140171692-A1 PROCESS FOR ASYMETRIC METHYLALLYLATION IN THE PRESENCE OF A 2,2'-SUBSTITUTED 1,1'-BI -2-NAPHTHOL CATALYST BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-06-19 — — US disclosed
US-20140171692-A1 PROCESS FOR ASYMETRIC METHYLALLYLATION IN THE PRESENCE OF A 2,2'-SUBSTITUTED 1,1'-BI -2-NAPHTHOL CATALYST BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-06-19 — — US disclosed
US-20140171692-A1 PROCESS FOR ASYMETRIC METHYLALLYLATION IN THE PRESENCE OF A 2,2'-SUBSTITUTED 1,1'-BI -2-NAPHTHOL CATALYST BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-06-19 — — US disclosed
US-20140135493-A1 METHODS OF MAKING DIASTEREOMERIC ORGANIC COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-05-15 — — US disclosed
US-20140135493-A1 METHODS OF MAKING DIASTEREOMERIC ORGANIC COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-05-15 — — US disclosed
US-20140135493-A1 METHODS OF MAKING DIASTEREOMERIC ORGANIC COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-05-15 — — US disclosed
EP-2655349-A1 METHODS OF MAKING DIASTEREOMERIC ORGANIC COMPOUNDS Boehringer Ingelheim International GmbH (DE) 2013-10-30 — — EP disclosed
WO-2012122152-A1 PROCESS FOR ASYMETRIC METHYLALLYLATION IN THE PRESENCE OF A 2, 2 ' - SUBSTITUTED 1, 1 ' -BI - 2 -NAPHTHOL CATALYST BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-09-13 — — WO disclosed
WO-2012087720-A1 METHODS OF MAKING DIASTEREOMERIC ORGANIC COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-06-28 — — WO disclosed
WO-2012087720-A1 METHODS OF MAKING DIASTEREOMERIC ORGANIC COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-06-28 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140171692-A1 PROCESS FOR ASYMETRIC METHYLALLYLATION IN THE PRESENCE OF A 2,2'-SUBSTITUTED 1,1'-BI -2-NAPHTHOL CATALYST HSD11B1, HSD11B2, HSD17B1 ALDH1A1 111/4885KDM4E 941/4885NPSR1 803/4885
US-20140135493-A1 METHODS OF MAKING DIASTEREOMERIC ORGANIC COMPOUNDS HSD11B1, HSD11B2, HSD17B1 ALDH1A1 74/4885KDM4E 2119/4885NPSR1 868/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback